Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 9.345 USD 0.81% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Applied Therapeutics Inc?
Write Note

Wall Street
Price Targets

APLT Price Targets Summary
Applied Therapeutics Inc

Wall Street analysts forecast APLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLT is 13.056 USD with a low forecast of 11.11 USD and a high forecast of 14.7 USD.

Lowest
Price Target
11.11 USD
19% Upside
Average
Price Target
13.056 USD
40% Upside
Highest
Price Target
14.7 USD
57% Upside
Applied Therapeutics Inc Competitors:
Price Targets
300601
Shenzhen Kangtai Biological Products Co Ltd
21% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
54% Upside
300685
Amoy Diagnostics Co Ltd
24% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
29% Upside
ALKS
Alkermes Plc
20% Upside
CSL
CSL Ltd
17% Upside
ZNTL
Zentalis Pharmaceuticals Inc
200% Upside
BVXP
Bioventix PLC
39% Upside

Revenue
Forecast

Revenue Estimate
Applied Therapeutics Inc

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 3 years is 145%.

N/A
Past Growth
145%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-80%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APLT's stock price target?
Price Target
13.056 USD

According to Wall Street analysts, the average 1-year price target for APLT is 13.056 USD with a low forecast of 11.11 USD and a high forecast of 14.7 USD.

What is Applied Therapeutics Inc's Revenue forecast?
Projected CAGR
145%

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 3 years is 145%.

Back to Top